BetterScholar BetterScholar
10
Role
Title
Level Year L/R
🐜 Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
16 auth. A. Hendlisz, M. Van den Eynde, M. Peeters, G. Maleux, B. Lambert, J. Vannoote, K. De Keukeleire, C. Verslype, L. Defreyne, E. Van Cutsem, ... P. Delatte, T. Delaunoit, N. Personeni, M. Paesmans, J. Van Laethem, P. Flamen
8 2010
8
🐜
🦁 Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.
11 auth. T. Delaunoit, S. Alberts, D. Sargent, Eva Grace Green, R. Goldberg, J. Krook, ... C. Fuchs, R. Ramanathan, S. Williamson, R. Morton, B. Findlay
7 2005
7
🦁
🐜 Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.
13 auth. R. Maréchal, B. Vos, M. Polus, T. Delaunoit, M. Peeters, P. Demetter, A. Hendlisz, A. Demols, D. Franchimont, G. Verset, ... P. V. Houtte, J. V. D. Stadt, J. Laethem
7 2012
7
🐜
🦁 Colorectal cancer prognosis among patients with inflammatory bowel disease.
T. Delaunoit, P. Limburg, R. Goldberg, J. Lymp, E. Loftus
7 2006
7
🦁
🦁 The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?
13 auth. T. Delaunoit, M. Ducreux, V. Boige, C. Dromain, J. Sabourin, P. Duvillard, M. Schlumberger, T. Baère, P. Rougier, P. Ruffié, ... D. Elias, P. Lasser, E. Baudin
7 2004
7
🦁
🦁 Pathogenesis and Risk Factors of Small Bowel Adenocarcinoma: A Colorectal Cancer Sibling?
T. Delaunoit, F. Neczyporenko, P. Limburg, C. Erlichman
6 2005
6
🦁
🐜 Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies
164 auth. P. Gibbs, V. Heinemann, N. Sharma, J. Taieb, J. Ricke, M. Peeters, M. Findlay, B. Robinson, Christopher Jackson, A. Strickland, V. Gebski, Mark Van Buskirk, Huaqing Zhao, G. V. van Hazel, Michael Brown, ... M. burge, G. Cardaci, S. Clarke, P. Eliadis, T. Ferguson, V. Ganju, Philip James, C. Karapetis, W. Liauw, G. Marx, M. Matos, L. Nott, N. Pavlakis, A. Powell, T. Price, D. Ransom, E. Segelov, J. Shannon, N. Singhal, E. Walpole, M. Craninx, T. Delaunoit, A. Deleporte, M. Ferrante, K. Geboes, A. Hendlisz, K. Hendrickx, M. De Man, E. Monsaert, V. Moons, M. Peeters, M. Polus, E. Boucher, J. Balosso, P. Chevallier, S. Louafi, M. Pracht, C. Rebischung, Denis Smith, É. Terrebonne, Harald-Robert Bruch, G. Gehbauer, T. Helmberger, Y. Ko, H. Kröning, F. Lammert, A. Nusch, S. Pluntke, K. Ridwelski, J. Riera-Knorrenschild, H. Riess, J. Riera, T. Sauerbruch, K. Scheidhauer, O. Stötzer, K. Tatsch, U. Vehling‐Kaiser, T. Vogl, A. Beny, R. Geva, E. Shacham-Shmueli, S. Stemmer, T. Tichler, I. Wolf, B. Angelelli, A. Martoni, M. Findlay, R. Isaacs, A. O’Donnell, D. Perez, B. Robinson, Javier Rodríguez, Ruth Vera-García, P. Amin, D. Bloomgarden, J. Bui, J. Carlisle, S. Chai, Yi-Jen Chen, M. Chuong, A. Coveler, F. Facchini, G. Frenette, Jacob C Frick, Michael Garofalo, Benjamin George, M. Gordon, S. Gulec, J. Hannigan, M. Holtzman, A. Kaubisch, A. Kaiser, Todd Kooy, S. Limentani, J. Margolis, Robert Martin, H. Ozer, S. Padia, W. Rilling, M. Savin, Elyse Schneiderman, Grant R. Seeger, N. Sharma, S. Shibata, Randall L. Smith, E. Wang, S. Whiting, M. Aghmesheh, M. Burge, P. Cooray, K. Feeney, L. Lim, M. Singh, C. Underhill, A. Deleporte, A. Durand, S. Faivre, A. Ferru, P. Hammel, C. Bremer, M. de Wit, H. Ayala, N. Heching, A. Shani, C. Granetto, G. Masi, S. Mosconi, G. Numico, A. Trogu, Yeul-Hong Kim, Han Sae-Won, Christopher Jackson, A. O’Donnell, M. Fragoso, I. Tan, A. Casado, Jingfei Liang, Jin Hwang Liu, S. Ades, M. Auber, P. Boland, C. Bowers, M. Crain, K. Dowling, R. Iyer, L. Ratner, F. Sanchez, P. Stoltzfus, M. Westcott
6 2018
6
🐜
🦁 Mortality associated with daily bolus 5‐fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin
12 auth. T. Delaunoit, R. Goldberg, D. Sargent, R. Morton, C. Fuchs, B. Findlay, ... Sachdev Thomas, M. Salim, P. Schaefer, P. Stella, E. Green, J. Mailliard
6 2004
6
🦁
🐜 Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials
16 auth. N. Charette, C. Vandeputte, L. Ameye, C. Bogaert, J. Krygier, T. Guiot, A. Deleporte, T. Delaunoit, K. Geboes, J. Van Laethem, ... M. Peeters, G. Demolin, S. Holbrechts, P. Flamen, M. Paesmans, A. Hendlisz
6 2019
6
🐜
🐜 Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: a randomized, double-blind, phase 2 trial - REACHIN.
12 auth. A. Demols, I. Borbath, M. Eynde, G. Houbiers, Monika Peeters, R. Maréchal, ... T. Delaunoit, J.-C. Goemine, Stéphanie Laurent, S. Holbrechts, Marianne Paesmans, J. V. Laethem
6 2020
6
🐜